A convertible note is a short-term loan that turns into equity at a future priced round. A SAFE is an agreement that promises the same conversion without the loan part — no interest, no maturity date. Both let a startup raise money now and argue about valuation later.
Which one founders pick depends less on the paperwork and more on who is across the table. SAFEs dominate early-stage and angel deals because they are short, standard and cheap to negotiate. Convertible notes show up more often with bridge investors, venture debt-style lenders and anyone who wants a fixed end date and interest for the wait. The differences are small on paper and large at conversion time.
This piece walks through the four terms that separate them — interest, maturity, valuation caps and conversion mechanics — and where each instrument fits. For the broader contrast with priced equity rounds, see SAFE Notes vs Priced Rounds: Mechanics, Cost, and Control.
What exactly is a convertible note?
A convertible note is debt, full stop. The investor lends money to the company. The note carries an interest rate and a maturity date — the day the loan comes due if no priced round has happened. When a priced round does happen, the note converts into shares, usually at a discount to the round price or at a valuation cap, whichever gives the investor the better deal.
Because it is debt, the note sits on the balance sheet as a liability. If the company runs out of money before the maturity date, note holders are creditors. In a shutdown, they stand ahead of common shareholders in line for whatever is left. That creditor position is the quiet reason some investors prefer notes.
What exactly is a SAFE?
A SAFE — a Simple Agreement for Future Equity — is not debt. There is no interest rate and no maturity date. The investor puts money in now, and the agreement converts into shares at the next priced round, again usually with a discount or a valuation cap. If no round ever happens, the SAFE can simply sit there; it does not come due.
The standard SAFE documents are short and widely used, which is their main selling point. A founder and an angel can sign one in an afternoon without term-sheet negotiation over interest, covenants or repayment. The trade-off is that the investor takes on more risk with fewer protections — no maturity forces a reckoning, and no interest compensates the wait.
How do interest and maturity change the deal?
These are the two terms SAFEs simply do not have, and they matter most when a round takes longer than anyone planned.
- Interest. A note's interest typically accrues and adds to the amount that converts. The investor ends up with slightly more shares than the face amount of the check. A SAFE converts at face value only.
- Maturity. If a note hits its maturity date with no priced round, the note holder has leverage. Depending on the terms, they can demand repayment, negotiate an extension — often with sweeter terms — or in some structures force a conversion. A SAFE holder has no such trigger.
For founders, that maturity date is the risk. A bridge that was supposed to last six months can become a repayment demand during the worst fundraising stretch of the company's life. That scenario is one reason bridge math deserves its own analysis — see Bridge Rounds: The Runway Math Before You Take One.
What do valuation caps actually do?
Both instruments usually carry a valuation cap: the maximum company valuation at which the early investor's money converts. If the next round prices above the cap, the note or SAFE holder converts as if the company were worth only the cap — earning more shares for the same check. If it prices below the cap, the discount usually governs instead.
The cap is where the real money changes hands. A cap set too low means early investors take a larger slice of the next round, and the founders' and employees' ownership shrinks more than the headline round size suggests. Because SAFEs have no interest to offset, founders and investors often bargain harder over the cap itself. Multiple SAFEs with different caps, signed at different times, can stack into a messy conversion waterfall — worth reading alongside What a Down Round Actually Does to Your Cap Table, Ratchet by Ratchet.
Which instrument fits which situation?
The honest answer is that the market has sorted itself into rough lanes.
- Pre-seed and angel rounds: SAFEs, overwhelmingly. The amounts are small, the investors want simplicity, and nobody wants to negotiate a maturity schedule over a $25,000 check.
- Bridge rounds from existing institutional investors: convertible notes more often. The investor is extending credit to a company it already knows, and wants interest and a maturity date as compensation for the risk that the next round never prices.
- Venture-debt-style lenders: notes or note-like structures, always. These are lenders in fact, and debt documents come with covenants SAFEs cannot offer.
- Larger pre-priced rounds with sophisticated parties: either, negotiated term by term.
When a founder wants the loan structure without equity conversion at all, that is a different product entirely — Venture Debt: When a Loan Beats a Round covers where straight debt beats both instruments.
Our analysis: the maturity date is the real decision
Strip away the legal vocabulary and the choice comes down to one question: who carries the risk if the next round is late? With a SAFE, the investor carries it — no interest, no repayment right, no deadline. With a note, the company carries it — the clock runs, interest accrues, and maturity gives the investor a lever.
Founders choosing a note should price that lever in. Ask what happens at maturity, who decides, and what an extension costs. Founders choosing a SAFE should assume the investor knows they are carrying more risk, and expect that to show up in a lower cap or a larger discount. Neither instrument is free; they just bill in different currencies — one in interest and repayment risk, the other in conversion economics.
What the record does not settle is how often notes actually convert at maturity versus get extended, and how that varies by stage. That figure exists somewhere in aggregate fund data, but this desk has not seen a source for it, so we leave it as an open question rather than guess. What is clear is the trend line: standard, short documents have won the early stage, and the note survives where debt-like protections matter — which is exactly where the money is largest and the riskiest.
Practical steps before you sign either one
- Model the conversion at your realistic next-round price, at the cap, and at the cap with accrued interest. The spread between those numbers is what you are giving away.
- If you sign a note, write down what happens at maturity and who has to agree to an extension. Ambiguity here favors the creditor.
- If you stack multiple SAFEs, keep a running list of caps and discounts. Conversion math gets ugly fast when the caps differ.
- Remember both instruments are temporary. They defer the valuation conversation; they do not eliminate it. The priced round — and its liquidation preferences — is where control is actually settled.
Neither document is a verdict on your company. They are postponements with different interest rates on the waiting. Pick the one whose risks you can actually carry, and know the date you are promising to make the deferral end.
Sources: therighthairstyles.com · latest-hairstyles.com · timeless-hairstyles.com · flawlesshair.com
